Search results

• Accessibility page

  Here is our Accessibility page

• Cookie Policy

  Here we list all Cookies used on this site

• C4C Lead via SnapEngage

  C4C Lead via SnapEngage

• Unsubscribe

  Unsubscribe from our promotional email lists

• Terms and condition page

  Here you can be updated on our Terms and conditions

• Industrial Specialties

  Industrial Specialties serves our retained businesses in coatings, textiles, fibers, water treatment, and niche industrial markets, providing essential formulation ingredients and sustainable solutions from key Croda manufacturing sites worldwide.

• Life Sciences

  We provide high-quality healthcare solutions, protect crops, and enhance seeds, supporting global health and crop sustainability. Our growing range of technologies ensures we deliver high value to customers worldwide.

• Consumer Care

  Consumer Care combines our businesses closest to consumers, offering innovative, sustainable solutions for home care, beauty, personal care, and fragrance. Our expertise enables us to provide tailored formulations to meet global consumer demands.

• Turkish Privacy Policy

  Here we explain how we use your data

• Polish privacy policy

  Here we explain how we use your data

• Image library

  View and download a range of our high-resolution images to accompany articles and information about Croda

• Our timeline

  View our timeline to discover how we became the global leader in naturally resourced, speciality chemicals.

• Non financial data pack Page Summary Title

  Non financial data pack Page Summary Description

• Acquisitions and partners Page Summary Title

  Acquisitions and partners Page Summary Description

• Appointments

  Stay informed with the latest news on executive and key appointments at Croda International Plc.

• Acquisitions and partners Page Summary Title

  Acquisitions and partners Page Summary Description

• Acquisitions and partners Page Summary Title

  Acquisitions and partners Page Summary Description

• Acquisitions and partners Page Summary Title

  Acquisitions and partners Page Summary Description

• Innovation at Croda: Beyond boundaries

  'Beyond boundaries' offers a range of content, covering a multitude of topics, all focused on innovation at Croda.

• Pharma seminar

  7 October 2022: Investor seminar, empowering biologics delivery in Pharma

• Consumer Care seminar

  29 March 2022: This event focused on how Croda’s Consumer Care sector has evolved significantly in recent years, becoming a highly differentiated sector for Croda, comprising four business units, each with leading market positions in fast growth niches.

• Fragrances & Flavours investor site visit

  12 May 2022: Presentation articulating the compelling growth plan for our F&F business as part of an investor site visit.

• Full year 2021 results announcement webinar

  View the full webinar from our full year results announcement 2021, results for the year ended 31 December 2021.

• Investor seminar to launch our 2020 Sustainability Report

  25 March 2021: Steve Foots, CEO and other senior members of our management team launched our 2020 Sustainability Report.

• Half year results announcement 2022 webinar

  View the full webinar from our half year results announcement 2022, results for the six months ended June 2022.

• Full year 2021 results announcement webinar

  View the full webinar from our half year results announcement 2021, results for the six months ended June 2021.

• Full year 2023 results announcement webinar

  View the full webinar from our half year results announcement 2023.

• First quarter 2025 results call

  Listen to our update on trading from 01 January to 31 March.

• First quarter 2024 results call

  Update on trading from 01 January to 31 March.

• Alert service

  Receive email alert notifications of announcements

• Whistleblowing policy speak up Page Summary Title

  Whistleblowing policy speak up Page Summary Description

• Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants

  3 March 2022: Croda International Plc, announces today that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental life-science research institute.

• Croda joins the World Business Council for Sustainable Development

  Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today joined over 200 of the world’s leading sustainable companies as the newest member of the World Business Council for Sustainable Development (WBCSD).

• Launch of Croda Pharma

  23 May 2022: Our Health Care division becomes Croda Pharma

• Investments in North American Field Crops Business

  Leading seed treatment company Incotec announces two significant investments in its North American business.

• Acquisition of IonPhasE

  Acquisition of an innovative technology supplier of static electricity protection products.

• Croda joins KTN SME accelerator programme

  Supporting UK-based SMEs and start-ups to bring their technology closer to market through the KTN accelerator programme

• Incroslip SL Granted European Food Contact Approval

  Our novel slip additive Incroslip SL has been granted European food contact approval

• Knowledge Transfer Partnership with York University

  This KTP will see Croda work with the university developing novel algorithms for product comparison and quality control.

• Two new partnerships for the pharmaceutical industry

  Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

• Sustainability expert Aris Vrettos joins Croda

  The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further enhancing their sustainability strategies by working in partnership with their customers and suppliers.

• Croda appoints Chief Financial Officer

  1 July 2024: Croda International Plc, today announces that the Board has appointed Stephen Oxley as Chief Financial Officer (CFO) and Executive Director.

• Directorate change

  John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and will be replaced by Ian Bull.

• Appointment of Non-Executive Director

  24 March 2023: We are pleased to announce the appointment of Non-Executive Director, Chris Good

• Appointment of Non-Executive Director

  25 June 2024: We are pleased to announce the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024.

• Appointment of Chairman Designate

  Croda announces announces that it has appointed Anita Frew as a Non-Executive Director and Chairman Designate.

• Appointment of Chair Designate

  22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate

• Appointment of Non-Executive Director

  7 January 2022: We are pleased to announce the appointment of Non-Executive Director, Nawal Ouzren

• Pharma investor seminar

  Empowering biologics delivery in Pharma

• Transition to a dedicated Consumer Care and Life Sciences company

  Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company